UMB Bank n.a. Has $92,000 Position in GE HealthCare Technologies Inc. $GEHC

UMB Bank n.a. lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 43.2% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 1,238 shares of the company’s stock after selling 942 shares during the quarter. UMB Bank n.a.’s holdings in GE HealthCare Technologies were worth $92,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vident Advisory LLC boosted its holdings in shares of GE HealthCare Technologies by 14.3% during the fourth quarter. Vident Advisory LLC now owns 5,893 shares of the company’s stock worth $461,000 after acquiring an additional 738 shares during the period. Vise Technologies Inc. acquired a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $246,000. Toronto Dominion Bank boosted its stake in GE HealthCare Technologies by 71.5% in the 4th quarter. Toronto Dominion Bank now owns 263,565 shares of the company’s stock valued at $20,606,000 after purchasing an additional 109,875 shares during the period. Mackenzie Financial Corp grew its holdings in GE HealthCare Technologies by 0.9% in the 4th quarter. Mackenzie Financial Corp now owns 80,728 shares of the company’s stock valued at $6,311,000 after buying an additional 755 shares in the last quarter. Finally, Ameriflex Group Inc. bought a new position in GE HealthCare Technologies during the 4th quarter worth $31,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of recent research reports. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Morgan Stanley set a $74.00 price objective on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Zacks Research upgraded shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 28th. BTIG Research reiterated a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Finally, Citigroup increased their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $88.40.

GE HealthCare Technologies Stock Down 0.8%

NASDAQ GEHC opened at $73.98 on Thursday. The business has a fifty day moving average price of $74.51 and a two-hundred day moving average price of $73.03. The stock has a market capitalization of $33.78 billion, a PE ratio of 15.16, a PEG ratio of 2.85 and a beta of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter in the previous year, the firm earned $1.00 EPS. GE HealthCare Technologies’s revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.